Pliant Therapeutics Adopts Limited Duration Stockholder Rights Agreement
Provided By GlobeNewswire
Last update: Mar 13, 2025
SOUTH SAN FRANCISCO, Calif., March 13, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that its Board of Directors has unanimously adopted a limited duration stockholder rights agreement (the “Rights Agreement”) to protect stockholder interests.
Read more at globenewswire.com
